Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 24 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (5)
P 1 (1)
P 2 (2)

Trial Status

Recruiting8
Unknown7
Completed7
Not Yet Recruiting1
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT07563660Not ApplicableRecruitingPrimary

FAPI PET/CT Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) (FAPI-ARVC))

NCT03049254RecruitingPrimary

Mayo AVC Registry and Biobank

NCT06040242Not ApplicableRecruitingPrimary

Arrhythmogenic Activity During Exercise in ARVC Patients

NCT06174220Phase 2Recruiting

Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy

NCT03177018Not ApplicableCompleted

DNA Analysis From Isolated Cardiomyocytes in the Molecular Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

NCT02432092Recruiting

Pediatric Cardiomyopathy Mutation Analysis

NCT06228924Phase 1RecruitingPrimary

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

NCT06748261Not Yet Recruiting

AI-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary CTA

NCT06311708RecruitingPrimary

Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

NCT03685149Phase 2CompletedPrimary

Pilot Randomized Trial With Flecainide in ARVC Patients

NCT04265040Recruiting

DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies

NCT05799833Unknown

Low QRS Voltages in Young Healthy Individuals and Athletes

NCT05024708Not ApplicableUnknownPrimary

Athlete's Heart or Arrhythmogenic Right Ventricular Cardiomyopathy: Contribution of Exercise Cardiovascular Magnetic Resonance (CMR)

NCT04895540UnknownPrimary

South Asian Arrhythmogenic Cardiomyopathy Registry

NCT00292032Completed

Registry of Unexplained Cardiac Arrest

NCT01804699CompletedPrimary

National ARVC Data Registry and Bio Bank

NCT04124237Completed

Long Term Monitoring for Risk of Sudden Death

NCT02302274Completed

Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome

NCT03527342Enrolling By Invitation

Sahlgrenska Cardiomyopathy Project

NCT02989480Unknown

PET-detected Myocardial Inflammation is a Characteristic of Cardiac Sarcoid But Not of ARVC

Scroll to load more

Research Network

Activity Timeline